![Vaccines | Free Full-Text | Heterologous Prime-Boost Vaccination with Inactivated Influenza Viruses Induces More Effective Cross-Protection than Homologous Repeat Vaccination Vaccines | Free Full-Text | Heterologous Prime-Boost Vaccination with Inactivated Influenza Viruses Induces More Effective Cross-Protection than Homologous Repeat Vaccination](https://pub.mdpi-res.com/vaccines/vaccines-11-01209/article_deploy/html/images/vaccines-11-01209-g001.png?1688655494)
Vaccines | Free Full-Text | Heterologous Prime-Boost Vaccination with Inactivated Influenza Viruses Induces More Effective Cross-Protection than Homologous Repeat Vaccination
![Frontiers | Heterologous Prime-Boost Vaccination Enhances TsPmy's Protective Immunity against Trichinella spiralis Infection in a Murine Model Frontiers | Heterologous Prime-Boost Vaccination Enhances TsPmy's Protective Immunity against Trichinella spiralis Infection in a Murine Model](https://www.frontiersin.org/files/Articles/277847/fmicb-08-01394-HTML/image_m/fmicb-08-01394-g001.jpg)
Frontiers | Heterologous Prime-Boost Vaccination Enhances TsPmy's Protective Immunity against Trichinella spiralis Infection in a Murine Model
![Does the immunization order of vaccine types influence the efficacy of heterologous prime-boost vaccination, especially mRNA and protein-based vaccines? Does the immunization order of vaccine types influence the efficacy of heterologous prime-boost vaccination, especially mRNA and protein-based vaccines?](https://d2jx2rerrg6sh3.cloudfront.net/images/news/ImageForNews_735119_16730368638805478.jpg)
Does the immunization order of vaccine types influence the efficacy of heterologous prime-boost vaccination, especially mRNA and protein-based vaccines?
![Heterologous Prime Boost Vaccination Induces Protective Melanoma-Specific CD8+ T Cell Responses: Molecular Therapy - Oncolytics Heterologous Prime Boost Vaccination Induces Protective Melanoma-Specific CD8+ T Cell Responses: Molecular Therapy - Oncolytics](https://www.cell.com/cms/attachment/f7dbbfb6-5278-4a3e-8c90-f1ee99d59889/fx1_lrg.jpg)
Heterologous Prime Boost Vaccination Induces Protective Melanoma-Specific CD8+ T Cell Responses: Molecular Therapy - Oncolytics
![A Prime-Boost Strategy Using Virus-Like Particles Pseudotyped for HCV Proteins Triggers Broadly Neutralizing Antibodies in Macaques | Science Translational Medicine A Prime-Boost Strategy Using Virus-Like Particles Pseudotyped for HCV Proteins Triggers Broadly Neutralizing Antibodies in Macaques | Science Translational Medicine](https://www.science.org/cms/10.1126/scitranslmed.3002330/asset/dbc539bc-0d12-4603-a5da-f094eced241e/assets/graphic/3-94ra71-f4.jpeg)
A Prime-Boost Strategy Using Virus-Like Particles Pseudotyped for HCV Proteins Triggers Broadly Neutralizing Antibodies in Macaques | Science Translational Medicine
![Heterologous prime-boost vaccination against tuberculosis with recombinant Sendai virus and DNA vaccines | Journal of Molecular Medicine Heterologous prime-boost vaccination against tuberculosis with recombinant Sendai virus and DNA vaccines | Journal of Molecular Medicine](https://media.springernature.com/lw685/springer-static/image/art%3A10.1007%2Fs00109-019-01844-3/MediaObjects/109_2019_1844_Fig1_HTML.png)
Heterologous prime-boost vaccination against tuberculosis with recombinant Sendai virus and DNA vaccines | Journal of Molecular Medicine
![Heterologous prime-boost with AdC68- and mRNA-based COVID-19 vaccines elicit potent immune responses in mice | Signal Transduction and Targeted Therapy Heterologous prime-boost with AdC68- and mRNA-based COVID-19 vaccines elicit potent immune responses in mice | Signal Transduction and Targeted Therapy](https://media.springernature.com/full/springer-static/image/art%3A10.1038%2Fs41392-021-00843-6/MediaObjects/41392_2021_843_Fig1_HTML.png)
Heterologous prime-boost with AdC68- and mRNA-based COVID-19 vaccines elicit potent immune responses in mice | Signal Transduction and Targeted Therapy
![Frontiers | Heterologous Prime-Boost Combinations Highlight the Crucial Role of Adjuvant in Priming the Immune System Frontiers | Heterologous Prime-Boost Combinations Highlight the Crucial Role of Adjuvant in Priming the Immune System](https://www.frontiersin.org/files/MyHome%20Article%20Library/336322/336322_Thumb_400.jpg)
Frontiers | Heterologous Prime-Boost Combinations Highlight the Crucial Role of Adjuvant in Priming the Immune System
![A Prime-Boost Strategy Using Virus-Like Particles Pseudotyped for HCV Proteins Triggers Broadly Neutralizing Antibodies in Macaques | Science Translational Medicine A Prime-Boost Strategy Using Virus-Like Particles Pseudotyped for HCV Proteins Triggers Broadly Neutralizing Antibodies in Macaques | Science Translational Medicine](https://www.science.org/cms/10.1126/scitranslmed.3002330/asset/d3130cb8-33c3-4484-8657-c92302918f92/assets/graphic/3-94ra71-f5.jpeg)
A Prime-Boost Strategy Using Virus-Like Particles Pseudotyped for HCV Proteins Triggers Broadly Neutralizing Antibodies in Macaques | Science Translational Medicine
Heterologous Prime-Boost Enhances the Antitumor Immune Response Elicited by Plant-Virus-Based Cancer Vaccine | Journal of the American Chemical Society
![JCI Insight - Antibody effector analysis of prime versus prime-boost immunizations with a recombinant measles-vectored chikungunya virus vaccine JCI Insight - Antibody effector analysis of prime versus prime-boost immunizations with a recombinant measles-vectored chikungunya virus vaccine](https://df6sxcketz7bb.cloudfront.net/manuscripts/151000/151095/medium/jci.insight.151095.ga.jpg)
JCI Insight - Antibody effector analysis of prime versus prime-boost immunizations with a recombinant measles-vectored chikungunya virus vaccine
![Heterologous prime–boost vaccination with ChAdOx1 nCoV-19 and BNT162b2 - The Lancet Infectious Diseases Heterologous prime–boost vaccination with ChAdOx1 nCoV-19 and BNT162b2 - The Lancet Infectious Diseases](https://www.thelancet.com/cms/attachment/4f775784-4453-4c08-98f1-01483f865da7/gr1_lrg.jpg)
Heterologous prime–boost vaccination with ChAdOx1 nCoV-19 and BNT162b2 - The Lancet Infectious Diseases
![Reactogenicity and immunogenicity of heterologous prime-boost immunization with COVID-19 vaccine - ScienceDirect Reactogenicity and immunogenicity of heterologous prime-boost immunization with COVID-19 vaccine - ScienceDirect](https://ars.els-cdn.com/content/image/1-s2.0-S0753332222000385-ga1.jpg)
Reactogenicity and immunogenicity of heterologous prime-boost immunization with COVID-19 vaccine - ScienceDirect
![Full article: Immunogenicity and reactogenicity of heterologous prime-boost vaccination with inactivated COVID-19 and ChAdOx1 nCoV-19 (AZD1222) vaccines, a quasi-experimental study Full article: Immunogenicity and reactogenicity of heterologous prime-boost vaccination with inactivated COVID-19 and ChAdOx1 nCoV-19 (AZD1222) vaccines, a quasi-experimental study](https://www.tandfonline.com/cms/asset/3fa03438-6a23-47ef-9572-4f6979200137/khvi_a_2206360_f0006_oc.jpg)
Full article: Immunogenicity and reactogenicity of heterologous prime-boost vaccination with inactivated COVID-19 and ChAdOx1 nCoV-19 (AZD1222) vaccines, a quasi-experimental study
![Cancers | Free Full-Text | Heterologous Prime-Boost Vaccination with a Peptide-Based Vaccine and Viral Vector Reshapes Dendritic Cell, CD4+ and CD8+ T Cell Phenotypes to Improve the Antitumor Therapeutic Effect Cancers | Free Full-Text | Heterologous Prime-Boost Vaccination with a Peptide-Based Vaccine and Viral Vector Reshapes Dendritic Cell, CD4+ and CD8+ T Cell Phenotypes to Improve the Antitumor Therapeutic Effect](https://pub.mdpi-res.com/cancers/cancers-13-06107/article_deploy/html/images/cancers-13-06107-ag.png?1638930543)
Cancers | Free Full-Text | Heterologous Prime-Boost Vaccination with a Peptide-Based Vaccine and Viral Vector Reshapes Dendritic Cell, CD4+ and CD8+ T Cell Phenotypes to Improve the Antitumor Therapeutic Effect
![An extended SARS-CoV-2 mRNA vaccine prime-boost interval enhances B cell immunity with limited impact on T cells - ScienceDirect An extended SARS-CoV-2 mRNA vaccine prime-boost interval enhances B cell immunity with limited impact on T cells - ScienceDirect](https://ars.els-cdn.com/content/image/1-s2.0-S2589004222021770-fx1.jpg)
An extended SARS-CoV-2 mRNA vaccine prime-boost interval enhances B cell immunity with limited impact on T cells - ScienceDirect
![Vaccines | Free Full-Text | Heterologous Prime-Boost Vaccination with Inactivated Influenza Viruses Induces More Effective Cross-Protection than Homologous Repeat Vaccination Vaccines | Free Full-Text | Heterologous Prime-Boost Vaccination with Inactivated Influenza Viruses Induces More Effective Cross-Protection than Homologous Repeat Vaccination](https://www.mdpi.com/vaccines/vaccines-11-01209/article_deploy/html/images/vaccines-11-01209-g003.png)
Vaccines | Free Full-Text | Heterologous Prime-Boost Vaccination with Inactivated Influenza Viruses Induces More Effective Cross-Protection than Homologous Repeat Vaccination
![Evaluation of heterologous prime-boost vaccination strategies using chimpanzee adenovirus and modified vaccinia virus for TB subunit vaccination in rhesus macaques | npj Vaccines Evaluation of heterologous prime-boost vaccination strategies using chimpanzee adenovirus and modified vaccinia virus for TB subunit vaccination in rhesus macaques | npj Vaccines](https://media.springernature.com/m685/springer-static/image/art%3A10.1038%2Fs41541-020-0189-2/MediaObjects/41541_2020_189_Fig2_HTML.png)
Evaluation of heterologous prime-boost vaccination strategies using chimpanzee adenovirus and modified vaccinia virus for TB subunit vaccination in rhesus macaques | npj Vaccines
![Safety, reactogenicity, and immunogenicity of homologous and heterologous prime-boost immunisation with ChAdOx1 nCoV-19 and BNT162b2: a prospective cohort study - The Lancet Respiratory Medicine Safety, reactogenicity, and immunogenicity of homologous and heterologous prime-boost immunisation with ChAdOx1 nCoV-19 and BNT162b2: a prospective cohort study - The Lancet Respiratory Medicine](https://www.thelancet.com/cms/attachment/c9b82c52-e974-4657-a0ff-981c13faf48f/gr1_lrg.jpg)
Safety, reactogenicity, and immunogenicity of homologous and heterologous prime-boost immunisation with ChAdOx1 nCoV-19 and BNT162b2: a prospective cohort study - The Lancet Respiratory Medicine
![Heterologous Prime-Boost Enhances the Antitumor Immune Response Elicited by Plant-Virus-Based Cancer Vaccine | Journal of the American Chemical Society Heterologous Prime-Boost Enhances the Antitumor Immune Response Elicited by Plant-Virus-Based Cancer Vaccine | Journal of the American Chemical Society](https://pubs.acs.org/cms/10.1021/jacs.9b01523/asset/images/medium/ja-2019-01523w_0007.gif)
Heterologous Prime-Boost Enhances the Antitumor Immune Response Elicited by Plant-Virus-Based Cancer Vaccine | Journal of the American Chemical Society
![Frontiers | Can Complementary Prime-Boost Immunization Strategies Be an Alternative and Promising Vaccine Approach Against Dengue Virus? Frontiers | Can Complementary Prime-Boost Immunization Strategies Be an Alternative and Promising Vaccine Approach Against Dengue Virus?](https://www.frontiersin.org/files/MyHome%20Article%20Library/476663/476663_Thumb_400.jpg)